Research ArticleMolecular Imaging
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
Thijs S. Stutvoet, Elly L. van der Veen, Arjan Kol, Inês F. Antunes, Erik F.J. de Vries, Geke A.P. Hospers, Elisabeth G.E. de Vries, Steven de Jong and Marjolijn N. Lub-de Hooge
Journal of Nuclear Medicine December 2020, 61 (12) 1839-1844; DOI: https://doi.org/10.2967/jnumed.119.241364
Thijs S. Stutvoet
1Departments of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Elly L. van der Veen
1Departments of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Arjan Kol
1Departments of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Inês F. Antunes
2Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and
Erik F.J. de Vries
2Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and
Geke A.P. Hospers
1Departments of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Elisabeth G.E. de Vries
1Departments of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Steven de Jong
1Departments of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Marjolijn N. Lub-de Hooge
2Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and
3Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 12
December 1, 2020
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
Thijs S. Stutvoet, Elly L. van der Veen, Arjan Kol, Inês F. Antunes, Erik F.J. de Vries, Geke A.P. Hospers, Elisabeth G.E. de Vries, Steven de Jong, Marjolijn N. Lub-de Hooge
Journal of Nuclear Medicine Dec 2020, 61 (12) 1839-1844; DOI: 10.2967/jnumed.119.241364
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
Thijs S. Stutvoet, Elly L. van der Veen, Arjan Kol, Inês F. Antunes, Erik F.J. de Vries, Geke A.P. Hospers, Elisabeth G.E. de Vries, Steven de Jong, Marjolijn N. Lub-de Hooge
Journal of Nuclear Medicine Dec 2020, 61 (12) 1839-1844; DOI: 10.2967/jnumed.119.241364
Jump to section
Related Articles
Cited By...
- 89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
- Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of 89Zr-Labeled Anti-PD-L1 Antibody Formats
- 18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study